Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry

PURPOSE: African Americans experience greater prostate cancer risk and mortality than do Caucasians. An analysis of pooled phase III data suggested differences in overall survival (OS) between African American and Caucasian men receiving sipuleucel-T. We explored this in PROCEED (NCT01306890), an FD...

Descripción completa

Detalles Bibliográficos
Autores principales: Sartor, Oliver, Armstrong, Andrew J., Ahaghotu, Chiledum, McLeod, David G., Cooperberg, Matthew R., Penson, David F., Kantoff, Philip W., Vogelzang, Nicholas J., Hussain, Arif, Pieczonka, Christopher M., Shore, Neal D., Quinn, David I., Small, Eric J., Heath, Elisabeth I., Tutrone, Ronald F., Schellhammer, Paul F., Harmon, Matthew, Chang, Nancy N., Sheikh, Nadeem A., Brown, Bruce, Freedland, Stephen J., Higano, Celestia S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423504/
https://www.ncbi.nlm.nih.gov/pubmed/32111923
http://dx.doi.org/10.1038/s41391-020-0213-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423504/
https://www.ncbi.nlm.nih.gov/pubmed/32111923
http://dx.doi.org/10.1038/s41391-020-0213-7

Ejemplares similares